top of page
Search


Think Ahead, Be Prepared – TGA Post-market Review
Recently, the Therapeutic Goods Administration (TGA) cancelled the registration of four COVID-19 rapid antigen tests...
Aug 11, 2022


TGA Follows FDA - COVID-19 Treatment Use Expanded
On 6 May 2022, the Therapeutic Goods Administration (TGA) provisionally approved the expanded use of Veklury (remdesivir) in Australia....
May 18, 2022


New TGA Consultation: Repurposing Medicines
The Therapeutic Goods Association (TGA) is conducting a public consultation concerning the repurposing of medicines listed...
Mar 23, 2022


FDA Policy Update: COVID-19-related Sanitation Tunnels
The FDA has expressed concern surrounding the safety and efficacy of sanitation tunnels developed to combat the spread of COVID-19.
Feb 11, 2022


The Future of Clinical Trials in the European Union, and the ‘ACT EU’ Initiative
The European Commission (EC), Heads of Medicines Agencies (HMA), and European Medicines Agency (EMA) recently published their initiative...
Jan 28, 2022
Top of page
bottom of page


